Insider Transactions in Q4 2024 at Praxis Precision Medicines, Inc. (PRAX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2024
|
Lauren Mastrocola Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
294
+4.74%
|
$10,878
$37.4 P/Share
|
|
Nov 14
2024
|
Timothy Edwin Kelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
205
+1.63%
|
$7,585
$37.4 P/Share
|
|
Nov 14
2024
|
Lauren Mastrocola Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,188
-48.04%
|
$420,228
$81.78 P/Share
|
|
Nov 14
2024
|
Lauren Mastrocola Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,374
+28.82%
|
$244,944
$56.94 P/Share
|
|
Nov 14
2024
|
Alex Nemiroff General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
8,239
-44.44%
|
$659,120
$80.2 P/Share
|
|
Nov 14
2024
|
Alex Nemiroff General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
7,583
+29.03%
|
$424,648
$56.94 P/Share
|